Press Releases

Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare

ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks

ClearNote Health announced an agreement with Claritev, Inc., (previously MultiPlan, Inc.) that will make ClearNote Health’s Avantect Pancreatic Cancer Test available to health plan members accessing Claritev’s national PHCS and MultiPlan Networks.

Augurex Announces UK Conformity Assessed (UKCA) Authorization for JOINTstat®, Expanding Access to Cutting-Edge Rheumatoid Arthritis Testing in Great Britain

Augurex has received UK Conformity Assessed marking for JOINTstat®, authorizing its use in Great Britain for rheumatoid arthritis diagnosis and management. JOINTstat® is a well-established rheumatoid arthritis blood test in North America, approved by Health Canada and available in the U.S. as a laboratory-developed test.

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

IQVIA Laboratories is introducing its Site Lab Navigator, an advanced suite of solutions that automates and streamlines lab workflows for clinical trial sponsors and investigator sites, aiming to significantly reduce administrative burden on sites and improve the quality and execution of trials.

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.

Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

Thermo Fisher Scientific’s New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics

Today, Thermo Fisher Scientific launched the Invitrogen™ EVOS™ S1000 Spatial Imaging System to offer scientists new capabilities to understand the organization of cells within tissues.

Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, marks its 10-year anniversary this month, a milestone that demonstrates the company’s long-term commitment to unlock the power of precision diagnostics, transform healthcare, and end the diagnostic odyssey for patients with the most complex genetic disorders.

Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares New RNA Sequencing Insights for Rare Disease at Precision Medicine World Conference 2025

Christine Eng, M.D., chief medical officer and chief quality officer at Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will present on new RNA sequencing insights for rare disease as part of the Clinical Dx (Diagnostic) Showcase track at the Precision Medicine World Conference (PMWC) 2025.

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Ambience Healthcare Joins athenahealth’s Marketplace Program to Support Clinicians with AI-assisted Documentation, Point of Care CDI & Coding, and Care Coordination

OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel

Ultra-low variant detection (including very large FLT3-ITDs) by OGT's new SureSeq™ Myeloid MRD Panel enables a stronger characterization of a sample’s current AML status

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

At Pharmapack Europe 2025, six exceptional start-ups have been honoured with the prestigious ‘Heart of Pharma’ awards, recognising their groundbreaking contributions to drug delivery, packaging, and patient care. Selected from a competitive field of 26 innovators, these companies are transforming healthcare with technologies that promise to revolutionize industry standards. The winners include innovations such as sustainable biofuel-powered electronics, patient-friendly nasal sprays, next-generation intradermal drug delivery devices, and breakthrough vial-filling systems. Representing global excellence, recipients hail from the U.S., UK, Ireland, France, and the DACH region. With over 6,000 attendees and 370 exhibitors, Pharmapack remains the must-attend event for pharma innovation. Don’t miss the chance to cover these transformative start-ups and their award-winning technologies.

Pharmapack Europe Awards 2025 Winners

Pharmapack Europe 2025 proudly announces the winners of its newly reformatted Pharmapack Awards, recognising excellence across six transformative categories in pharmaceutical packaging and drug delivery. This year’s honourees include innovative advancements in sustainable materials, patient-centered design, and next-generation devices—all poised to redefine healthcare delivery. Notable winners include SHL Medical’s Elexy™ reusable electromechanical autoinjector, Huhtamaki’s Omnilock™ Ultra PAPER for eco-friendly packaging, and Mitsubishi Gas Chemical’s OXYCAPT multilayer vial for gene therapy. The prestigious Woman of the Year Award celebrates Asmita Khanolkar of SMC Ltd. for her decades-long contributions to drug-device innovation.

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

* £500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis * Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need